✦ LIBER ✦

CN6 COST-EFFECTIVENESS OF A HUMAN PAPILLOMAVIRUS VACCINE IN REDUCING THE RISK OF CERVICAL CANCER IN IRELAND USING ATRANSMISSION DYNAMIC MODEL

✍ Scribed by C Usher; L Tilson; J Olsen; M Rudbeck Jepsen; C Walsh; M Barry

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Cost-effectiveness of human papillomavir

✍ Cara Usher; Lesley Tilson; Jens Olsen; Martin Jepsen; Cathal Walsh; Michael Barr 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 346 KB

Cost-effectiveness of using human papill

✍ Arthi Vijayaraghavan; Molly B. Efrusy; Karyn A. Goodman; Christopher C. Santas; 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 440 KB

PIH22 EVALUATING THE COST-EFFECTIVENESS

✍ DC Taylor; V Pawar; K Gilmore; M Sanon; D Kruzikas; M Kohli; B Arondekar; N Dema 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 97 KB

The potential cost-effectiveness of addi

✍ Edina Sinanovic; Jennifer Moodley; Mark A. Barone; Sumaya Mall; Susan Cleary; Ja 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 367 KB

PCN98 Estimating the Potential Cost-Effe

✍ Damm, O.; Horn, J.; Kretzschmar, M.; Deleré, Y.; Kaufmann, A.M.; Wichmann, O.; K 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 59 KB

PCN15 ESTIMATING THE COST EFFECTIVENESS

✍ S Redmond; N Demarteau 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 70 KB